Combination of treatment with death receptor 5-specific antibody with therapeutic HPV DNA vaccination generates enhanced therapeutic antitumor effects

There is currently a vital need for the development of novel therapeutic strategies for the control of advanced stage cancers. Antigen-specific immunotherapy and the employment of antibodies against the death receptor 5 (DR5) have emerged as two potentially promising strategies for cancer treatment....

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tseng, Chih-Wen, Trimble, Cornelia, Monie, Archana, Alvarez, Ronald D., Huh, Warner K., Buchsbaum, Donald J., Straughn, J. Michael, Wang, Mei-Cheng, Yagita, Hideo, Hung, Chien-Fu, Wu, T.-C.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2008
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2614388/
https://ncbi.nlm.nih.gov/pubmed/18598733
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2008.06.049
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares